Latest Administration News

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.

Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.

Impact Minerals pushes its Lake Hope High Purity Alumina project into pilot production while its JV partner Kuniko hits mineralisation in every hole at Commonwealth, discovering new high-grade extensions.

Lode Resources (ASX:LDR) delivered a maiden JORC Mineral Resource Estimate at Montezuma, revealing 8.2Moz AgEq of high-grade silver-antimony, alongside a new silver-zinc mineralisation system that broadens exploration potential.

Pepper Money is set to become the servicer for a massive A$36 billion loan portfolio from HSBC Australia following its acquisition by a Blackstone-controlled entity, aligning with Pepper Money's strategy to expand its capital-light servicing business.

Azzuro Resources has locked in a major copper-gold discovery at its newly acquired Red Hill project in Mongolia, confirming a high-grade VMS system over nearly 550 metres of strike with significant expansion potential.

Broken Hill Mines (ASX: BHM) reported a 21.8% jump in silver output and a new high-grade bulk tonnage discovery at its Rasp Mine, underpinning strong operational momentum and a solid financial footing.

Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.

Rokeby Resources (ASX: RKB) has secured the high-grade Omeo Gold Project, renewed a key mining licence, and launched a drilling campaign at Sunnyside to upgrade historical gold resources while raising $4.34 million.

Everest Metals has reported strong progress across its Western Australian projects, including maiden and upgraded resource estimates at Revere, Mt Edon, and Mt Dimer, alongside advancing mining and proprietary processing technology.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

The Supreme Court of New South Wales has approved Zurich’s acquisition of ClearView, setting a clear timetable for scheme implementation and shareholder payouts.